While much of the mechanistic insight comes from preclinical studies, the accumulating clinical evidence underscores the importance of continued research into CGRP’s receptor interactions and signaling pathways, with the goal of improving and personalizing migraine treatment (Edvinsson, 2021). The gene discussed is CALCA; the disease is migraine disorder.